Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:III-365-III-369

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeuchi, K.
Right arrow Articles by McGowan, F. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeuchi, K.
Right arrow Articles by McGowan, F. X., Jr
Related Collections
Right arrow Contractile function
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Growth factors/cytokines

(Circulation. 2000;102:III-365.)
© 2000 American Heart Association, Inc.


Myocardial Protection and Vascular Biology

Vesnarinone Restores Contractility and Calcium Handling in Early Endotoxemia

Koh Takeuchi, MD; Pedro J. del Nido, MD; Dimitrios N. Poutias, BS; Douglas B. Cowan, PhD; Mamoru Munakata, MD; Francis X. McGowan, Jr, MD

From the Departments of Anesthesiology and Cardiac Surgery and the Anesthesia/Critical Care Medicine Laboratory, Children’s Hospital and Harvard Medical School, Boston, Mass.

Correspondence to Francis X. McGowan, Jr, Cardiac Anesthesia Service, Children’s Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail mcgowan_f{at}a1.tch.harvard.edu

Background—Endotoxin (lipopolysaccharide, LPS) is a trigger of the systemic inflammatory response. We have previously found that vesnarinone and amrinone, when given before LPS, prevented cytokine production and LPS-related cardiac dysfunction. We tested the hypothesis that vesnarinone would improve intracellular Ca2+ handling and calcium-activated contractile force after the onset of endotoxemia.

Methods and Results—Adult rabbits received a bolus injection of LPS or vehicle. Vesnarinone (3 mg/kg) was given intravenously 90 minutes later. Two hours after LPS administration, hearts were perfused in the isolated Langendorff mode. Peak left ventricular developed pressure, ±dp/dt, oxygen consumption (MO2), and ratexpressure product were evaluated in conjunction with fluorescent spectroscopic determinations of intracellular calcium concentrations (Cai) and the rate of Cai transient decline during diastole ({tau}Ca). Peak left ventricular developed pressure and ±dp/dt were significantly lower in the LPS group. These were completely restored by vesnarinone. There was significantly slower diastolic calcium removal (increased {tau}Ca) in LPS hearts that was also corrected by vesnarinone; however, the cytosolic calcium overload characteristic of LPS hearts was only partially improved. Reduced mechanical inefficiency (the ratio of rate-pressure product to MO2) and myofilament sensitivity to Cai were also significantly improved by vesnarinone.

Conclusions—Acute endotoxemia caused contractile protein calcium insensitivity, oxygen wastage, and abnormal calcium cycling. Vesnarinone, given in the rescue mode, normalized LPS-induced myocardial dysfunction and partially restored abnormal calcium cycling. Although the mechanisms responsible for these effects require further clarification, it appears that agents such as vesnarinone may be useful to treat inflammatory-induced myocardial dysfunction.


Key Words: calcium • contractility • proteins • inflammation